Operating System for EvidenceMD

Run your clinical AI company on autopilot

EvidenceMDOS is the autonomous operations layer for EvidenceMD. Growth metrics, competitive intelligence, physician outreach, and daily progress, all running without you having to manage it.

8+
Direct competitors mapped
$6B+
Competitor market cap tracked
24/7
Autonomous operations

Every growth function, automated

From tracking what OpenEvidence ships to finding your next 100 physicians, EvidenceMDOS handles the operational grind so you can focus on the product.

📊

Growth Metrics Dashboard

Real-time visibility into user adoption, feature engagement, retention curves, and revenue, all in one view built specifically for clinical AI products.

🔍

Competitive Intelligence

Automated monitoring of OpenEvidence, Vera Health, Suki, Doximity, Glass Health, and UpToDate. Know what they ship before their users do.

📧

Physician Outreach Engine

AI-powered cold outreach to clinicians in underserved markets. Personalized messages based on specialty, location, and clinical workflow pain points.

Daily Progress Cycles

Every day, Polsia ships work: research, engineering, marketing, growth. You wake up to progress reports, not task lists.

A crowded market with clear gaps

The clinical AI decision support space is exploding. Here's where the opportunity lives.

  • Most competitors are single-purpose Scribe OR decision support OR imaging. EvidenceMD bundles everything into one platform.
  • OpenEvidence is US-only 440K+ physician users, but restricted to licensed US doctors. International markets are wide open.
  • Multi-language is a moat EvidenceMD's multi-language support unlocks markets in India, SEA, Middle East, and Africa that US competitors ignore.
  • Price undercuts everyone UpToDate charges $500+/year. EvidenceMD's freemium model is a fundamentally different GTM.

The path forward

Win international markets first. Bundle scribe + decision support + imaging where competitors offer only one. Undercut on price while delivering more features. The clinical AI market hit $200M single rounds in 2025. The window is open, and EvidenceMD's positioning is right.

Clinical AI deserves better infrastructure

EvidenceMDOS runs growth, research, and operations for EvidenceMD autonomously. Every day, real progress ships. The future of evidence-based medicine runs itself.